GSK plc
- SEC CIK
- 0001131399
Holdings, Q2 2026
Positions as of Jun 30, 2026, filed Aug 13, 2026.SEC
- Positions
- 13
- 0 vs. Q1 2026
- Total value
- $602.22M
- +$3.07M (+0.5%) vs. Q1 2026
Compare with Q1 2026: new, added, reduced and sold out
Positions
Long positions only. Changes compare share counts with Q1 2026.
| Security | Class | Shares | Value | % of portfolio | Change in shares | Action | History |
|---|---|---|---|---|---|---|---|
| CRSPCRISPR THERAPEUTICS AG | NAMEN AKT | 3,220,627 | $175.65M | 29.17% | 00.0% | Unchanged | View |
| WVEWAVE LIFE SCIENCES LTD | SHS | 18,245,691 | $106.01M | 17.60% | 00.0% | Unchanged | View |
| VIRVIR BIOTECHNOLOGY INC | COM | 8,550,954 | $87.13M | 14.47% | 00.0% | Unchanged | View |
| BNTXBIONTECH SE | SPONSORED ADS | 889,824 | $82.8M | 13.75% | 00.0% | Unchanged | View |
| IDYAIDEAYA BIOSCIENCES INC | COM | 1,333,333 | $49.69M | 8.25% | 00.0% | Unchanged | View |
| CYTKCYTOKINETICS INC | COM NEW | 340,434 | $29M | 4.82% | 00.0% | Unchanged | View |
| LYELLYELL IMMUNOPHARMA INC | COM NEW | 1,512,659 | $21.25M | 3.53% | 00.0% | Unchanged | View |
| SPROSPERO THERAPEUTICS INC | COM | 9,190,606 | $20.31M | 3.37% | 00.0% | Unchanged | View |
| NKTXNKARTA INC | COM | 3,150,732 | $8.92M | 1.48% | 00.0% | Unchanged | View |
| FULCFULCRUM THERAPEUTICS INC | COM | 1,785,714 | $6.54M | 1.09% | 00.0% | Unchanged | View |
| BCYCBICYCLE THERAPEUTICS PLC | SPONSORED ADS | 1,529,561 | $6.49M | 1.08% | 00.0% | Unchanged | View |
| CVRXCVRX INC | COM | 1,007,583 | $5.18M | 0.86% | 00.0% | Unchanged | View |
| RGNXREGENXBIO INC | COM | 271,456 | $3.25M | 0.54% | 00.0% | Unchanged | View |
13F filings by quarter
| Quarter | Filed | Positions | Total value | Changes | Filing |
|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | 13 | $602.22M | vs. Q1 2026 | SEC |
| Q1 2026 | May 14, 2026 | 13 | $599.15M | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 12, 2026 | 15 | $799.02M | – | SEC |